Since the approval of four cholinesterase inhibitors in the 1990s and memantine in 2003, there have been no new treatments for Alzheimer’s disease. Against this backdrop, Paul Aisen of the University of California, San Diego, opened the 4th International Conference on Clinical Trials on Alzheimer’s Disease (CTAD) on 3 November ... continue reading
(Ivanhoe Newswire) — It’s been 27 years since the clinical diagnostic criteria for Alzheimer’s disease has been revised. Research guidelines for prior stages of the disease have been characterized to reflect a deeper comprehension of the disorder that affects someone every 70 seconds in the U.S., making it the fifth ... continue reading
Brand:
Average Rating
0 reviews
The third edition of this successful textbook has been completely updated throughout and includes new chapters on electrophysiological tests, biological markers, global staging measures, and management of neuropsychiatric symptoms. There has been steady progress in our understanding of the ... continue reading
Brand:
Average Rating
1 review
As the essays in this volume show, conceptualizing dementia has always been a complex process. With contributions from noted professionals in psychiatry, neurology, molecular biology, sociology, history, ethics, and health policy, Concepts of Alzheimer Disease looks ... continue reading